Skip to main content
OpenTrials
Completed

NCT Number: NCT01226589

Pharmacist Discharge Medication Reconciliation Study

Adverse drug events can occur commonly due to medication errors during the transition of care in a health care facility. Medication reconciliation is the process of comparing medications and providing an accurate medication list as a resource for prescribers, which is currently only being done upon inpatient admission at the CCI. The purpose of this study is to see if pharmacist medication reconciliation at discharge reduces unintentional medication discrepancies for inpatient discharges.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Medication Reconciliation Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cross Cancer Institute

Edmonton, Alberta, T6G 1Z2, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cancer inpatients under the care of Dr. Follett or Dr. Candler
  • Cancer inpatients to be discharged from the CCI
  • Patients >18 years of age
  • Patients that are taking >1 medications or herbals total at home.

Exclusion criteria

  • Cancer inpatients that are considered radioactive or in "hot rooms" (ie. Selectron patients or patients receiving radiation treatment for thyroid)
  • Patients that do not remain in hospital >72 hours
  • Patients without a home phone number or equivalent contact number.
  • Language barrier (patients unable to speak or understand English).
  • Patients that are readmitted and already included into the study.

Treatment and study plan

MRS

Procedure

Primary outcomes

  1. MRS Correlation with Treatment Response.

    Time frame: up to 1 year

    The percentage of patients with at least one unintentional medication discrepancy after discharge from the Cross Cancer Institute

Secondary outcomes

  1. Correlation with Tumor Stage

    Time frame: up to 1 year

    The amount of medication discrepancies after discharge that has the potential to cause moderate harm to severe harm.

  2. The frequency of each type of unintentional medication discrepancies.

Sponsors and collaborators

Lead sponsor

Alberta Health services

Other

Registry information

Official study title

The Impact of Pharmacist Discharge Medication Reconciliation on Unintentional Medication Discrepancies From Inpatient Discharges at the Alberta Cancer Board Cross Cancer Institute

Important dates

Study start
2007
Study completion
2008
First posted
Oct 22, 2010
Registry last updated
Apr 19, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.